Trial description:
Adjuvant canakinumab vs placebo in stages II-IIIB resected NSCLC
Contact name:
Dr Gary Doherty
Trial start date:
Wednesday, April 17, 2019
Trial end date:
Wednesday, June 30, 2021
Trial tumour type:
Lung
Show on Radiotherapy:
No
